May 18, 2020 / By Elizabeth Cohen, Senior Medical Correspondent
(CNN) – Study subjects who received Moderna’s Covid-19 vaccine had positive early results, according to the biotech company, which partnered with the National Institutes of Health to develop the vaccine.
If future studies go well, the company’s vaccine could be available to the public as early as January, Dr. Tal Zaks, Moderna’s chief medical officer, told CNN. 
“This is absolutely good news and news that we think many have been waiting for for quite some time,” Zaks said.
These early data come from the Phase 1 clinical trial, which typically studies a small number of people and focuses on whether a vaccine is safe and elicits an immune response.